AKT1 and cancer: Treatment of human cancer cells with 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), the pharmacologic activator of AMPK, has been reported to inhibit cell proliferation and induce apoptosis by several mechanisms, including modulating the MAPK and the PI3K/Akt pathways [15].